NCT03421613View on ClinicalTrials.gov

3VM1001 Cream for the Treatment of Pain Associated With Post Herpetic Neuralgia (PHN)

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 6, 2017

Primary Completion Date

March 30, 2018

Study Completion Date

May 4, 2018

Conditions
Treatment of PHN
Interventions
DRUG

3VM1001

Self treatment 3 times daily for 10 days

OTHER

Placebo

Cream without investigational drug. Self treatment 3 times daily for 10 days

Trial Locations (2)

10036

Medex Healthcare Reasearch, Inc., New York

60602

Medex Healthcare Research, Inc., Chicago

Sponsors
All Listed Sponsors
lead

CDA Research Group, Inc.

INDUSTRY